Health Care & Life Sciences » Pharmaceuticals | United Laboratories International Holdings Ltd.

United Laboratories International Holdings Ltd. | Mutual Funds

Mutual Funds that own United Laboratories International Holdings Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Government Pension Fund - Global (The)
21,427,133
1.31%
4,635,691
0%
12/31/2017
DFA International Small Cap Value Portfolio
7,152,000
0.44%
-1,302,000
0.04%
04/30/2018
Vanguard Total International Stock Index Fund
6,448,627
0.39%
0
0%
07/31/2018
DFA Asia Pacific Small Company Series
6,004,000
0.37%
380,000
0.27%
01/31/2018
4,042,000
0.25%
0
0.93%
09/06/2018
DFA International Core Equity Portfolio
3,727,500
0.23%
0
0.01%
04/30/2018
iShares MSCI EAFE Small Cap ETF
3,348,000
0.2%
0
0.03%
09/06/2018
Nationwide VIT - Emerging Markets Fund
3,033,226
0.19%
2,246,000
0.34%
05/31/2018
iShares Core MSCI EAFE ETF
2,780,000
0.17%
0
0%
09/06/2018
Standard Life Investment Co. ICVC - Global EM Equity Funds
2,735,185
0.17%
0
0.8%
08/31/2018

About United Laboratories International Holdings

View Profile
Address
6 Fuk Wang Street
Hong Kong
Hong Kong
Employees -
Website http://www.tul.com.cn
Updated 07/08/2019
United Laboratories International Holdings Ltd. operates as an investment company, which engages in the manufacturing and sale of medicines, and the bulk and intermediate products used to produce finished goods. It operates through the following segments: Intermediate Products, Bulk Medicine, and Finished Products. The Intermediate Products segment offers two major products, such as T-Octylammonium Clavulanate and 6-APA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.